{"": [91, 100, 0, 101, 1157, 0, 1158, 2014, 0], "INTRODUCTION": [2015, 5308, 0], "Early COVID-19 pandemic convalescent cohort and prepandemic controls.": [5318, 6309, 0], "Characterization of an early pandemic cohort with Wuhan strain sequences.": [6310, 9674, 0], "NAb responses to emerging SARS-CoV-2 variants in early pandemic sera.": [9675, 11101, 0], "Correlates of emerging SARS-CoV-2 variant cross-neutralization.": [11102, 13257, 0], "RESULTS": [5309, 13257, 1], "DISCUSSION": [13258, 18087, 0], "Patient enrollment.": [18111, 18849, 0], "Enzyme-linked immunosorbent assay.": [18850, 19724, 0], "Multiplexed electrochemiluminescence assay.": [19725, 20576, 0], "Pseudovirus neutralization assay.": [20577, 21661, 0], "IFN-\u03b3 enzyme-linked immune absorbent spot assay.": [21662, 22398, 0], "Statistical methods.": [22399, 23434, 0], "MATERIALS AND METHODS": [18088, 23434, 1]}